Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
PaperCitations, authors & open-access status
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 888 citations, 2013 year and closed oa status.
888
Citations
2013
Year
closed
OA Status